These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


107 related items for PubMed ID: 6897434

  • 1. [Pirenzepine--an anticholinergic agent with selective antimuscarinic properties].
    Dotevall G, Jaup BH, Stockbrügger RW.
    Lakartidningen; 1982 Oct 13; 79(41):3671-3. PubMed ID: 6897434
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of gastric acid secretion by selective and nonselective anticholinergics.
    Feldman M.
    Gastroenterology; 1984 Feb 13; 86(2):361-6. PubMed ID: 6360787
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Selective muscarinic receptor antagonists].
    Kishimoto S, Kajiyama G, Miyoshi A.
    Nihon Rinsho; 1984 Jan 13; 42(1):114-9. PubMed ID: 6371305
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Does pirenzepine distinguish between 'subtypes' of muscarinic receptors?
    Szelenyi I.
    Br J Pharmacol; 1982 Dec 13; 77(4):567-9. PubMed ID: 6897522
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Mechanism of action of the gastric secretion inhibitor Pirenzepin].
    Hammer R, Koss FW.
    Fortschr Med; 1980 Apr 10; 98(14):(549-54). PubMed ID: 6892811
    [No Abstract] [Full Text] [Related]

  • 15. Muscarinic receptor blockade by pirenzepine: effect on prolactin secretion in man.
    Masala A, Alagna S, Devilla L, Rovasio PP, Rassa S, Faedda R, Satta A.
    J Endocrinol Invest; 1982 Apr 10; 5(1):53-5. PubMed ID: 6808052
    [Abstract] [Full Text] [Related]

  • 16. Muscarinic receptor subclasses: evidence from binding studies.
    Birdsall NJ, Hulme EC, Stockton J, Burgen AS, Berrie CP, Hammer R, Wong EH, Zigmond MJ.
    Adv Biochem Psychopharmacol; 1983 Apr 10; 37():323-9. PubMed ID: 6688916
    [No Abstract] [Full Text] [Related]

  • 17. Pirenzepine--a ligand with original binding properties to muscarinic receptors.
    Birdsall NJ, Burgen AS, Hammer R, Hulme EC, Stockton J.
    Scand J Gastroenterol Suppl; 1980 Apr 10; 66():1-4. PubMed ID: 6941372
    [Abstract] [Full Text] [Related]

  • 18. Effect of pirenzepine on L--amino acids stimulated gastric acid secretion and serum gastrin levels in peptic ulcer disease in men.
    Bertoglio S, Anfossi A, Arnulfo G, Valentini P, Berti Riboli E.
    Scand J Gastroenterol Suppl; 1982 Apr 10; 72():179-84. PubMed ID: 6957988
    [Abstract] [Full Text] [Related]

  • 19. Differential antagonism by dicyclomine, pirenzepine and secoverine at muscarinic receptor subtypes in the rat frontal cortex.
    Marchi M, Raiteri M.
    Eur J Pharmacol; 1985 Jan 02; 107(2):287-8. PubMed ID: 3838514
    [No Abstract] [Full Text] [Related]

  • 20. Nicotinic-cholinergic involvement in arginine-vasopressin response to insulin-induced hypoglycemia in normal men.
    Coiro V, Butturini U, Gnudi A, Delsignore R, Volpi R, Chiodera P.
    Metabolism; 1986 Jul 02; 35(7):577-9. PubMed ID: 3523115
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.